- Headquarters
- Wilmington, Delaware
- Employees
- 51–200
- Business Model
- B2B
- Total Funding
- $85.0M
- Last Round
- $50.0M Series CAug 2020
- Rounds
- 2
- Type
- Public
About
Precision oncology company developing innovative medicines targeting areas of high unmet need in cancer treatment.
Summary
Prelude Therapeutics is a Biotech company based in Wilmington, United States. It has raised $85.0M in total across 2 rounds, most recently a $50.0M Series C round in Aug 2020. Investors include OrbiMed, RA Capital Management and Fidelity Management.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform